Epidemiology of hospital-acquired bloodstream infections in haemato-oncology patients in Geneva, Switzerland.

ABSTRACT:

Background

Hospital-acquired bloodstream infections (HA-BSI), including catheter-associated bloodstream infections (CABSI), cause preventable harm in haemato-oncology patients but surveillance data are limited.

Methods

We performed a retrospective cohort study using prospectively collected data in a large hospital network in Switzerland from 2017-2022. Incidence, source, and microbiology of HA-BSI were compared between (1) haematology patients with acute leukaemia or allogeneic stem cell transplantation (2) oncology patients with solid tumour or lymphoma, and (3) general medical patients. No routine quinolone prophylaxis was prescribed.

Results

We included 320,058 patient-days and 201,081 catheter-days across two haematology, two oncology and nine non-COVID-19 general

SUBMITTER: MacPhail A 

PROVIDER: S-EPMC12460527 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature